Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1643
This examiner grants 38% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17936216 | METHODS FOR IDENTIFYING A CELL UPTAKE MECHANISM | Non-Final OA | The Regents of the University of California |
| 18196402 | EXPANDED VACUUM-STABLE GELS FOR MULTIPLEXED HIGH RESOLUTION SPATIAL HISTOPATHOLOGY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17502152 | MODIFIED EXTRACELLULAR MATRIX-BASED HYDROGEL, MANUFACTURING METHOD OF THE SAME AND USE OF THE SAME | Final Rejection | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 17774645 | DROPLET DEFORMATION-BASED METHOD OF TRANSFERRING MATERIAL INTO CELLS AND CHIP FOR SAME | Non-Final OA | Korea University Research and Business Foundation |
| 17801408 | COMPOSITION FOR INDUCING BROWNING, CONTAINING MILK EXOSOMES | Final Rejection | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY |
| 17904023 | METHOD FOR PRODUCING AVATAR MOUSE AS ATOPIC DERMATITIS ANIMAL MODEL AND USE THEREOF | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 17963601 | NANOBARRIER AND METHOD OF REGULATING MACROPHAGE ADHESION AND POLARIZATION USING THE SAME | Non-Final OA | Industry-University Cooperation Foundation Hanyang University ERICA Campus |
| 18033639 | MODIFIED SIGNAL PEPTIDE | Non-Final OA | KAO CORPORATION |
| 18466854 | METHOD FOR ASSESSING RESPIRATORY VIRAL INFECTIONS | Non-Final OA | The University of Hong Kong |
| 18262341 | STEM CELL IN WHICH IMMUNE CELL TOLERANCE MODULATOR IS OVEREXPRESSED, AND USE THEREOF | Non-Final OA | UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION |
| 18271503 | PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS | Non-Final OA | Ecole Polytechnique Federale de Lausanne (EPFL) |
| 17904441 | PLATELET PRODUCTION METHOD AND DEVICE | Final Rejection | KYOTO UNIVERSITY |
| 17753708 | ANC80 ENCODING SPHINGOLIPID-METABOLIZING PROTEINS FOR MITIGATING DISEASE-INDUCED TISSUE DAMAGE | Non-Final OA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI |
| 17876993 | Method of Demineralizing Bone with an Ionic Solution | Non-Final OA | Newsouth Innovations Pty Limited |
| 18424292 | COMPOUNDS AND METHODS FOR TREATMENT OF DIAMOND BLACKFAN ANEMIA | Non-Final OA | THE CHILDREN'S MEDICAL CENTER CORPORATION |
| 17810982 | PLASMODIUM VIVAX MALE GAMETE FUSION PROTEIN PVHAP2 AND THE PUTATIVE PROLIFERATING-CELL NUCLEOLAR ANTIGEN P120 AS RELAPSE BIOMARKERS | Final Rejection | Seattle Children's Hospital dba Seattle Children's Research Institute |
| 17712452 | BIOSYNTHESIS OF ALPHA-IONONE AND BETA-IONONE | Non-Final OA | Conagen Inc. |
| 18268167 | EXPANDED AND STIMULATED NATURAL KILLER CELLS | Non-Final OA | GC Cell Corporation |
| 18247519 | Advanced Cell-Permeable Peptide Carriers | Non-Final OA | MUSC FOUNDATION FOR RESEARCH DEVELOPMENT |
| 18043818 | SQUALENE HOPENE CYCLASE DERIVATIVES AND USE THEREOF FOR PRODUCING AMBROX | Non-Final OA | INTERNATIONAL FLAVORS & FRAGRANCES, INC. |
| 17916340 | METHOD FOR PREPARING CULTURE MEDIUM CONTAINING HIGH LEVELS OF HIGH-POTENCY EXOSOMES SECRETED BY CORD BLOOD STEM CELLS, AND USE THEREOF | Non-Final OA | PRIMORIS THERAPEUTICS Co., Ltd. |
| 18033470 | METHODS FOR PROCESSING FETAL SUPPORT TISSUE | Non-Final OA | BioTissue Holdings Inc. |
| 18157599 | COMPOSITION AND METHOD FOR TREATING EYE DISEASES | Non-Final OA | Frontera Therapeutics, Inc. |
| 17912953 | METHOD FOR THE PRODUCTION AND PURIFICATION OF MULTIVALENT IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS | Non-Final OA | Ablynx NV |
| 17295122 | MARKER FOR DETECTING PROLIFERATION OF STEM CELL AND HIGH-EFFICIENCY PROLIFERATION METHOD OF STEM CELL USING SAME | Non-Final OA | Encell Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy